Overview

Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the efficacy and safety of Sarecycline versus placebo in the treatment of microcirculation dysfunction after reperfusion therapy in patients with large vessel occlusion stroke.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Tiantan Hospital
Collaborator:
NeuroDawn Pharmaceutical Co., Ltd.
Treatments:
Sarecycline